Abstract. 27
Kinetic analyses of diverse physiological processes have the potential to unveil new aspects of the 28 molecular regulation of cell biology at temporal levels. 17β-estradiol (E2) regulates diverse 29 physiological effects by binding to the estrogen receptor α (ERα), which primarily works as a 30 transcription factor. Although many molecular details of the modulation of ERα transcriptional 31 activity have been discovered including the impact of receptor plasma membrane localization and 32 its relative E2-evoked signalling, the knowledge of real-time ERα transcriptional dynamics in living 33 cells is lacking. Here, we report the generation of MCF-7 and HeLa cells stably expressing a 34 modified luciferase under the control of an E2-sensitive promoter, which activity can be 35 continuously monitored in living cells and show that E2 induces a linear increase in ERα 36 transcriptional activity. Ligand-independent (e.g., epidermal growth factor) receptor activation was 37 also detected in a time-dependent manner. Kinetic profiles of ERα transcriptional activity measured 38 in the presence of both receptor antagonists and inhibitors of ERα plasma membrane localization 39 reveals a biphasic dynamic of receptor behaviour underlying novel aspects of receptor-regulated 40 transcriptional effects. Finally, analysis of the rate of the dose-dependent E2 induction of ERα 41 transcriptional activity demonstrates that low doses of E2 induce an effect identical to that 42 determined by high concentrations of E2 as a function of the duration of hormone administration. 43
Overall, we present the characterization of sensitive stable cell lines where to study the kinetic of 44 E2 transcriptional signaling and to identify new aspects of ERα function in different physiological 45 or pathophysiological conditions. 46
Introduction.
growth once every 15 min, medium was changed, and cells were grown in 1% DCC medium in the 135 presence or in the absence of E2 (1 nM) and remained in the medium until the end of the 136 experiment. Cellular responses were then recorded once every 15 min for a total time of 72 hours. 137
For comparison of the effect of E2 in each cell line, the ratio between the normalized cell 138 index (NCI) (obtained by the ACEA Biosciences software) of the mean value for the E2-treated 139 samples and the NCI of the mean value for control sample was calculated and shown as a function 140 of time. 141 142 Real-time measurement of NanoLucPest expression. 143 MCF-7 ERE-NLuc cells were seeded in 96 well plates (5000 cells/well). Twenty-four hours 144 after plating, medium was changed, and cells were grown in 1% DCC medium for 24 hours and 145 then stimulated with E2. Each experimental condition was plated in triplicate and 3 wells were 146 always treated with fulvestrant (ICI182,240) (Sigma Aldrich) in order to measure the basal ERα 147 transcriptional activity. HeLa ERE-NLuc cells were transfected with the indicated ERα encoding 148 plasmids or with vector control. Twenty-four hours after transfection cells were seeded in 96 well 149 plates (5000 cells/well) and subsequently treated as described for MCF-7 ERE-NLuc cells. Nano-7 Glo® Endurazine TM was added according to manufacturer's instruction in 50µl as final 151 experimental volume together with ligand and/or inhibitor administration. Plates were then 152 transferred into a Tecan Spark microplate reader (Switzerland) set to 37°C and 5% CO2. Before any cellular and biochemical assay, cells were grown in 1% DCC medium for 24 162 hours and then stimulated with E2 at the indicated time points and doses. Cells were lysed in YY 163 buffer (50 mM HEPES at pH 7.5, 10% glycerol, 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, 1 164 mM EGTA) plus protease and phosphatase inhibitors. Western blotting analyses were performed by 165 loading 20-30 µg of protein on SDS-gels. Gels were run and transferred to nitrocellulose 166 membranes with Biorad Turbo-Blot semidry transfer apparatus. Immunoblotting was carried out by 167 incubating membranes with 5% milk (60 min), followed by incubation o.n. with the indicated 168 antibodies. Secondary antibody incubation was continued for an additional 60 min. Bands were 169 detected using a Biorad Chemidoc apparatus. 170 171 BrdU Incorporation. 172 Bromodeoxiuridine (BrdU) was added in the last 30 minutes to the medium and then cells 173 were fixed, permeabilized, and the histones were dissociated with 2 M HCl as previously described 174 (Darzynkiewicz and Juan, 2001) . BrdU positive cells were detected with an anti-BrdU primary 175 antibody diluted 1:100 (DAKO Cytomatation) and with an anti-mouse-Alexa488 conjugated diluted fluorescence was measured using a CytoFlex flow cytometer and the cell cycle analysis was 178 performed by CytExpert v1.2 software (Beckman Coulter). All samples were counterstained with 179 propidium iodide (PI) for DNA/BrdU biparametric analysis. 180 181
Cell cycle analysis 182
After treatments, cells were harvested with trypsin, and counted to obtain 10 6 cells per 183 condition. Then, the cells were centrifuged at 1500 rpm for 5 min at 4°C, fixed with 1 ml ice-cold 184 
Results. 198

Characterization of MCF-7 NLuc cells. 199
Characterization of the generated MCF-7 ERE-NLuc cells was performed by evaluating the 200 ability of E2 to induce cell proliferation (Castoria et al., 2001) , S118 ERα phosphorylation (Ali et 201 al., 1993) , ERα degradation (Leclercq et al., 2006) as well as the accumulation of two well-known 202 ERE-containing genes (i.e., presenilin 2 -pS2/TFF and cathepsin D -CatD) (Sun et al., 2005) . 203
Growth curves analyses indicated that E2 induced a persistent time-dependent increase in cell 204 number in MCF-7 ERE-NLuc cells ( Fig. 2A -green line). Interestingly, E2 was also able to increase 205 the number of parental MCF-7 cells with the same kinetics ( Fig. 2A -red line). As control, we also 206 measured the ability of E2 to increase the number of T47D-1, another ERα expressing breast cancer 207 cell line (Wilson et al., 2004) . Figure 2A E2-induced S118 phosphorylation of the ERα is required for receptor transcriptional activity 215 (Ali et al., 1993) . Therefore, we tested if E2 could trigger this receptor post-translational 216 modification in MCF-7 ERE-NLuc cells. Time-course analyses revealed that E2 rapidly (5 min) and 217 persistently (2 hours) increased the fraction of the S118 phosphorylated ERα in MCF-7 ERE-NLuc 218 cells, which peaked after 30 min of E2 administration ( Fig. 2D and D'). 219
Because E2-induced ERα degradation is intrinsically connected with receptor transcriptional 220 activity (Metivier et al., 2003; Reid et al., 2003) and we noted that E2 also determined a rapid and 221 persistent reduction in ERα intracellular levels ( Fig. 2D ), we next evaluated the ability of E2 to 222 trigger ERα degradation. Figure 2E and 2E' show that in 24 hours E2 reduced ERα content in MCF-223 7 ERE-NLuc cells in a dose-dependent manner. 224
Next, we finally tested the ability of E2 to modulate the expression of the ERE-containing 225 genes pS2/TFF and CatD. As shown in figure 3B and 3C, the levels of both pS2/TFF and CatD 226 were increased by 24 hours of E2 treatment in MCF-7 ERE-NLuc cells in a dose-dependent manner. 227
Overall, these data indicate that the MCF-7 ERE-NLuc cells respond to E2 as expected for an 228 E2 sensitive cell line derived from the parental MCF-7 cells. Figure 3A' shows a dose-dependent trend in the slope of the 245 curves relative to E2 administration. In particular, no differences were observed among the slopes 246 of the curves that refers to the cells treated with doses of E2 ranging from 10 -10 to 10 -8 M while the 247 slope extracted from the 10 -11 M E2-treated cells was significantly lower (Fig. 3A') . Notably, the 248 slope of the cells treated with 10 -12 M E2 was identical to that of the control samples ( Fig. 3A') . figure 3C , the E2-dependent increase in both ERE-254 NLuc activity, pS2/TFF and CatD expression was described by a sigmoidal curve typical of the E2 255 effect. Remarkably, the excitatory dose 50 (ED50) calculated for ERE-NLuc activity was lower 256 (ED50= 5.0 10 -12 M -5 pM) than the one calculated for Western blotting analysis of pS2/TFF and 257
CatD cellular levels (ED50= 2.5 10 -11 M -250 pM) ( Fig. 3C) . Therefore, the ERE-NLuc activity 258 assay is sensitive to E2 administration. 259
Next, we evaluated the involvement of ERα in the E2-induced ERE-NLuc activity by 260 administering the ERα antagonist 4OH-tamoxifen (Tam). As shown in figure Overall, these data demonstrate that E2 induces a rapid and persistent liner increase in ERα 281 transcriptional activity which can be detected at low doses of E2 (i.e., between 10 -12 to 10 -11 M) and 282 can be prevented by antiestrogens (e.g., Tam) and further suggest that the differences in the effects 283 elicited by E2 at different doses could depend on the rate at which E2 induces ERα transcriptional E2-induced ERα S118 phosphorylation is also required for full receptor transcriptional activity (Ali 314 et al., 1993) , we also tested the effects of E2 in ERα S118A mutant transfected HeLa ERE-NLuc 315
cells. 316
As shown in figure 6A and 6B, 2-Br treatment of MCF-7 ERE-NLuc cells prevented the E2-317 induced effect on the ERE-NLuc activity and strongly reduced the slope of the curve derived by E2 318 administration. Similar results were also obtained in wild type (wt) and C447A ERα mutant 319 transfected HeLa ERE-NLuc cells treated with E2 ( Fig. 6D and 6E ). Notably, as expected for a 320 receptor defective in S118 phosphorylation (Ali et al., 1993) , the E2 the kinetic profile as well as its 321 relative slope was reduced in S118A ERα mutant transfected HeLa ERE-NLuc cells with respect to 322 HeLa ERE-NLuc cells expressing the wt receptor ( Fig. 6D and 6E) . 323
Interestingly, we noticed a complex kinetic profile of 2Br-treated MCF-7 ERE-NLuc cells.
2-324
Br treatment reduced the ERE-NLuc activity below the control. Indeed, within the first 5 hours of 325 treatment E2 was not able to trigger ERE-NLuc activation while from 5 to 24 hours of E2 326 administration, the hormone stimulated the ERE-NLuc reporter activity (Fig. 6C ). On the contrary, 327 the measured E2-dependent ERE-NLuc activation of the C447A ERα mutant in transfected HeLa 328
These results confirm that ERα palmitoylation is required for E2-induced ERα transcriptional 331 activity and further suggest that the E2-dpendent activation of ERα plasma membrane localized 332 receptor is necessary for both rapid and persistent activation of ERα transcriptional functions. 333 334
Prediction of dose-and time-dependent E2 effect on ERα transcriptional activity. 335
Finally, based on the slope of the transcriptional profile extracted by our E2 dose-dependent 336 analyses in MCF-7 ERE-NLuc cells ( Fig. 2A and 2B ), we reasoned that the results obtained from 337 our stable cell lines could allow to predict the time point at which different doses of E2 elicit the 338 same ERE-NLuc activity. In turn, we first calculated the time at which each dose of E2 determines 339 a specific amount of E2 effect (Fig. 7A ). On this basis, we hypothesized that 24 hours E2 340 administration at 10 -11 M would determine a transcriptional effect equal to those elicited by 18 hours 341 E2 administration at concentration ranging from 10 -10 M at 10 -8 M, as detected in ERE-NLuc assays 342 ( Fig. 7B) . 343
To verify this prediction, we treated both parental MCF-7 and MCF-7 ERE-NLuc cells with 344 E2 at 10 -11 M for 24 hours and with E2 at both 10 -10 M, 10 -9 M and 10 -8 M for 18 hours and measured 345 the pS2/TFF expression. As shown in figure 7C and 7C', E2 induced the same accumulation of 346 pS2/TFF intracellular levels at all the tested doses in both parental and artificial MCF-7 cell lines. 347
Remarkably, under these conditions E2 lost its dose-dependent effect (Fig. 3C ) on the induction of 348 pS2/TFF expression ( Fig. 7D) . pathways originating from the activation of the ERα at the plasma membrane is critical for full 429 receptor transcriptional activity. However, data presented here further demonstrate that besides 430 being a pre-requisite for the rapid initial stages of E2-induced ERα transcriptional activation (La 431 prolonged effect of ERα as a ligand-induced transcription factor. In support to this notion, the time-433 dependent kinetic profile of E2-induced transcriptional activity of the palmitoylation defective ERα 434 C447A mutant measured in HeLa-ERE NLuc cells was completely flat. Therefore, we conclude that 435 the plasma membrane localization of the ERα is necessary and sufficient for the induction of the 436 receptor transcriptional activity both for rapid and prolonged times of E2 administration. 437 Finally, we predicted the time-dependent transcriptional behavior of different doses of an ERα 438 ligand. Indeed, we have calculated the time required for different E2 concentrations to reach the 439 same transcriptional effects and effectively reported that treatments with different E2 concentrations 440 at different time points of both MCF-7-ERE NLuc and parental MCF-7 cells produced the same 441 increase in pS2/TFF expression. Physiological blood concentration of E2 fluctuates in healthy pre-442 menopausal woman between picomolar and nanomolar concentrations. However, the peak of E2 443 concentration in blood lasts for a maximum time of 48-72 hours. This peak is however sufficient to 444 induce all the physiological uterine modifications (Zittermann et al., 2000) . Our results suggest that 445 rather than the chronic exposure to E2, the time of E2 administration is critical to achieve the 446 maximal ERα transcriptional activity. In this respect, the pulsatile nature of E2 action under 447 physiological conditions would support such concept. However, future investigations are required 448 to establish if short E2 treatments could lead to fully and prolonged activation of ERα action. 449
In conclusion, we report a method to study the real-time kinetics of E2:ERα transcriptional 450 activity in live-cells using the generated MCF-7-ERE NLuc and HeLa-ERE NLuc stable cell lines. 
